Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedtime vs Morning ACEIs/ARBs for Non-dipping Hypertension in Hong Kong
NCT03284099Phase 4Terminated
- Sponsor
- The Chinese University of Hong Kong
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Proportion of non-dipping status at 6 weeks. Started Dec 2017; status: terminated.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03284099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03284099.